查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1572019

全球椎體成形術市場

Vertebroplasty
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球椎體成形術市場將達到4.267億美元

全球椎體成形術市場預估2023年為2.875億美元，預估至2030年將達4.267億美元，2023-2030年分析期間複合年成長率為5.8%。

美國市場預估為7,630萬美元，中國預期複合年成長率為8.5%

到 2023 年，美國椎體成形術市場預計將達到 7,630 萬美元。中國作為全球第二大經濟體，預計到 2030 年市場規模將達到 9,530 萬美元，2023 年至 2030 年分析期間複合年成長率為 8.5%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 3.3% 和 5.5%。在歐洲，德國的複合年成長率預計為 3.4%。

全球椎體成形術市場趨勢及促進因素總結

什麼是椎體成形術？

椎體成形術是一種尖端的微創手術技術，旨在治療主要由骨質疏鬆症、轉移性癌症和創傷引起的疼痛性椎體壓迫性骨折 (VCF)。在這項手術中，一種特殊的丙烯酸骨水泥（最常見的是聚甲基丙烯酸甲酯（PMMA））被直接注射到骨折的脊椎骨中以穩定脊椎骨并快速緩解疼痛。在椎體成形術中，外科醫生在連續、即時透視或 CT 影像引導下小心地將細針穿過皮膚插入骨折骨中，以精確注射骨水泥。骨水泥以半液體狀態注入，並在脊椎骨內快速硬化，有效恢復結構完整性並減少引起疼痛的微運動。椎體成形術特別有吸引力的地方在於它可以立即且持續地緩解疼痛，使患者在手術後立即恢復正常活動。椎體成形術通常建議用於對休息、疼痛管理和矯正器具等保守治療沒有反應的患者，並且已成為改善椎體骨折患者生活品質的重要選擇。此外，調查方法具有完善的安全性，且診斷影像技術、水泥成分和手術方法的最新進展大大降低了相關風險，使其在整形外科和神經外科領域中廣泛接受。

椎體成形術的主要優點和挑戰是什麼？

儘管椎體成形術的好處是多方面的，並且為椎體壓迫性骨折患者提供了顯著的臨床益處，但它並非沒有挑戰。它的主要優點之一是疼痛迅速且顯著減輕，通常在手術後數小時內，因此患者比傳統的開放性手術治療體驗到更大的緩解，可以快速恢復活動能力並恢復日常生活。這種恢復速度對於體力有限或患有多種使治療複雜化的併發症的老年患者尤其重要。此外，透過穩定骨折的脊椎骨，椎體成形術可以防止脊椎進一步崩壞和畸形，從而降低脊椎後凸（通常稱為「駝峰脂肪」）的風險。儘管有這些優點，椎體成形術在醫學界還是引起了相當大的爭議。主要原因是擔心注射材料從椎體滲漏到鄰近結構中，導致神經根受壓、栓塞和脊髓損傷，從而產生潛在的併發症。為了降低這種風險，在改進水泥配方方面取得了進展，例如使用更高黏度的水泥和改進注射技術，以便在手術過程中更容易控制。另一個重要的挑戰在於選擇適當的椎體成形術任務，因為效果因骨折的根本原因而異。椎體成形術在治療骨質疏鬆性骨折方面顯示出優異的效果，但其治療惡性病變或高衝擊力創傷引起的骨折的有效性仍在研究中，需要強調準確的患者評估和個體化治療計劃的必要性。

椎體成形術與其他治療方法相比如何？

儘管椎體成形術因其獨特的優點而成為某些類型椎體壓迫性骨折的首選治療方法，但它經常與其他技術（例如後凸成形術和脊椎融合手術）進行比較，與其他治療方法相比，每種技術都有其自身的優點和限制。一種相關的手術，後凸成形術，在注射水泥之前使用球囊壓實在脊椎骨內形成空腔，以恢復一些失去的脊椎骨高度並矯正脊柱畸形。骨骺成形術在減少脊椎彎曲和預防姿勢異常方面更有效，但通常比椎體成形術更昂貴且耗時。相較之下，椎體成形術更容易、更快、更便宜，因為骨水泥是直接注射的。脊椎融合手術是一種更具侵入性的手術選擇，通常僅在涉及多個脊椎骨的嚴重病例或脊椎嚴重不穩定性時才進行。該手術使用骨移植物和金屬硬體永久連接兩個或多個脊椎骨，這增加了複雜性、恢復時間和潛在的併發症。由於椎體成形術是微創手術，因此在局部麻醉下進行，並且通常在門診病人進行，這對於無法忍受侵入性手術所需的長時間麻醉或住院的老年或內科患者來說是理想的選擇。患者。此外，椎體成形術緩解疼痛和穩定骨折的成功率與更具侵入性的手術相當或更好，特別是對於快速緩解疼痛和恢復正常功能來說，如果這是您的主要治療目標，那麼這是一個非常有利的選擇。然而，這些方案的選擇取決於多種因素，包括椎體崩壞的程度、整體骨骼健康狀況以及在對每種治療方法的風險和益處進行徹底討論後患者的具體偏好。

哪些市場動態正在影響椎體成形術的發展？

椎體成形術市場的成長也受到多種因素的推動，例如骨質疏鬆症和相關椎體骨折盛行率的上升、手術技術的進步以及患者對微創治療方案的偏好的改變。全球老化是推動椎體成形術需求的關鍵因素，因為骨質疏鬆症在老年人中尤其普遍，尤其是停經後女性，導致需要治療椎體壓迫性骨折的患者數量急劇增加。此外，生物活性和滲透性水泥等創新水泥配方的引入提高了手術的安全性和結果，使椎體成形術對患者和醫療保健專業人員都更具吸引力。此外，診斷影像技術的改進，包括採用高清透視和即時 3D 成像，正在提高手術的精確度，並降低併發症和骨水泥滲漏的風險。此外，對門診治療和門診手術的日益偏好也有助於市場擴張。椎體成形術通常無需延長住院時間即可進行，從而降低了整體醫療成本並提高了患者滿意度。消費者行為趨勢表明，對恢復更快、對日常生活干擾更少的治療的需求不斷成長，進一步推動了椎體成形術的採用。醫療保健專業人員和患者對椎體骨折早期療育益處的認知不斷提高，導致了更積極的治療策略並擴大了潛在的患者群體。此外，新市場參與者的進入以及主要相關人員之間的戰略夥伴關係預計將增加競爭，促進創新，並使椎體成形術更容易獲得和成本更低。因此，在人口趨勢、技術創新以及不斷變化的患者和提供者偏好的支持下，椎體成形術市場在未來幾年將強勁成長。

受訪企業範例（共42家）

  • Alphatec Spine, Inc.
  • DePuy Synthes（Johnson & Johnson）
  • Globus Medical, Inc.
  • IZI Medial Products
  • Medtronic
  • Merit Medical Systems, Inc.
  • Rontis
  • SPINUS（BMK Global Medical Company）
  • Stryker Corporation
  • Zavation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP17642

Global Vertebroplasty Market to Reach US$426.7 Million by 2030

The global market for Vertebroplasty estimated at US$287.5 Million in the year 2023, is expected to reach US$426.7 Million by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030.

The U.S. Market is Estimated at US$76.3 Million While China is Forecast to Grow at 8.5% CAGR

The Vertebroplasty market in the U.S. is estimated at US$76.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$95.3 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Vertebroplasty Market - Key Trends and Drivers Summarized

What Is Vertebroplasty and How Does It Work?

Vertebroplasty is a cutting-edge, minimally invasive surgical procedure developed to treat painful vertebral compression fractures (VCFs) caused primarily by osteoporosis, metastatic cancers, or trauma. This procedure entails injecting a specialized acrylic bone cement, most commonly polymethylmethacrylate (PMMA), directly into the fractured vertebra to stabilize it and provide rapid pain relief. During vertebroplasty, the surgeon carefully inserts a thin needle through the skin into the fractured bone under continuous real-time fluoroscopic or CT imaging guidance to ensure precise placement of the cement. The cement is injected in a semi-liquid state and quickly hardens inside the vertebra, effectively restoring its structural integrity and reducing micromovements that are the source of pain. What makes vertebroplasty especially appealing is its ability to provide immediate and lasting pain relief, allowing patients to resume normal activities shortly after the procedure. It is typically recommended for patients who have not responded to conservative management, such as bed rest, pain medication, and bracing, making it a critical option for improving the quality of life in individuals with debilitating spinal fractures. Additionally, vertebroplasty has a well-established safety profile, and recent advancements in imaging techniques, cement composition, and procedural methodologies have significantly reduced the associated risks, making it a widely accepted therapeutic option in the orthopedic and neurosurgical communities.

What Are the Major Benefits and Challenges of Vertebroplasty?

The advantages of vertebroplasty are multifaceted, providing substantial clinical benefits to patients with vertebral compression fractures, yet the procedure is not without its challenges. One of its primary benefits is the rapid and significant reduction of pain, which often occurs within hours post-procedure, enabling patients to regain mobility and return to their daily routines much faster than traditional open surgical treatments. This accelerated recovery is particularly crucial for elderly patients with limited physical capacity and those who suffer from multiple comorbidities that complicate their treatment. Furthermore, by stabilizing the fractured vertebra, vertebroplasty prevents further collapse and deformation of the spine, reducing the risk of progressive kyphosis, commonly known as a "dowager’s hump." Despite these benefits, vertebroplasty has sparked considerable debate in the medical community, primarily due to concerns regarding cement leakage—a complication that occurs when the injected material extrudes from the vertebral body into adjacent structures, potentially causing nerve root compression, embolism, or spinal cord injury. To mitigate these risks, there have been advancements in cement formulations, including the use of higher viscosity cements and refined injection techniques that allow for better control during the procedure. Another significant challenge lies in the selection of appropriate candidates for vertebroplasty, as its efficacy varies depending on the underlying cause of the fracture. While it has shown excellent outcomes in treating osteoporotic fractures, its effectiveness in fractures caused by malignant lesions or high-impact trauma remains a subject of ongoing research, highlighting the need for precise patient evaluation and individualized treatment planning.

How Does Vertebroplasty Compare to Other Treatment Options?

Vertebroplasty stands out as a preferred treatment for certain types of vertebral compression fractures due to its unique benefits, but it is often compared to other procedures like kyphoplasty and spinal fusion, each of which has its own strengths and limitations. Kyphoplasty, a related procedure, involves the use of a balloon tamp to create a cavity within the vertebra before cement is injected, which helps to restore some of the lost vertebral height and correct spinal deformity. While kyphoplasty is more effective in reducing spinal curvature and preventing postural abnormalities, it is typically more expensive and time-consuming than vertebroplasty. Vertebroplasty, by contrast, involves direct cement injection, making it simpler, faster, and less costly. Spinal fusion, a more invasive surgical option, is usually reserved for severe cases involving multiple vertebrae or when there is significant spinal instability. This procedure involves placing bone grafts and metallic hardware to permanently join two or more vertebrae, which increases the complexity, recovery time, and the potential for complications. Due to its minimally invasive nature, vertebroplasty is performed under local anesthesia and often as an outpatient procedure, making it an ideal choice for elderly or medically fragile patients who cannot tolerate the prolonged anesthesia or hospitalization required for more invasive surgeries. Moreover, vertebroplasty’s success rate in alleviating pain and stabilizing the fracture is comparable to or even exceeds that of more invasive techniques, making it a highly favorable option, especially when quick pain relief and a return to normal function are primary treatment goals. However, the choice between these options depends on various factors such as the degree of vertebral collapse, overall bone health, and patient-specific preferences following a thorough discussion of the risks and benefits of each treatment modality.

What Are the Market Dynamics Shaping Vertebroplasty Growth?

The growth in the vertebroplasty market is driven by several factors, including the rising prevalence of osteoporosis and related vertebral fractures, advancements in procedural technology, and shifting patient preferences towards less invasive treatment options. The global aging population is a key driver of demand for vertebroplasty, as osteoporosis is particularly prevalent among older adults, especially postmenopausal women, leading to a surge in the number of patients requiring treatment for vertebral compression fractures. Furthermore, the introduction of innovative cement formulations, such as bioactive and radiopaque cements, has improved procedural safety and outcomes, making vertebroplasty a more attractive option for both patients and healthcare providers. Additionally, improvements in imaging techniques, including the adoption of high-definition fluoroscopy and real-time 3D imaging, have enhanced procedural precision, reducing the risk of complications and cement leakage. The growing preference for outpatient and ambulatory surgical settings has also contributed to the market expansion, as vertebroplasty can often be performed without the need for prolonged hospitalization, thereby reducing overall healthcare costs and increasing patient satisfaction. Consumer behavior trends indicate a rising demand for treatments that offer rapid recovery and minimal disruption to daily life, further fueling the adoption of vertebroplasty. Increased awareness among healthcare professionals and patients about the benefits of early intervention for spinal fractures has led to more proactive treatment strategies, expanding the potential patient base. Furthermore, the entry of new market players and strategic partnerships among key stakeholders are expected to boost competition, foster innovation, and drive down costs, making vertebroplasty more accessible. As a result, the vertebroplasty market is poised for robust growth in the coming years, supported by a combination of demographic trends, technological innovations, and evolving patient and provider preferences.

Select Competitors (Total 42 Featured) -

  • Alphatec Spine, Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Globus Medical, Inc.
  • IZI Medial Products
  • Medtronic
  • Merit Medical Systems, Inc.
  • Rontis
  • SPINUS (BMK Global Medical Company)
  • Stryker Corporation
  • Zavation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Vertebroplasty - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Spinal Compression Fractures Accelerates Vertebroplasty Adoption
    • Rising Geriatric Population Spurs Demand for Vertebroplasty Procedures
    • Increased Awareness of Minimally Invasive Spine Treatments Expands Market Opportunities
    • Advancements in Imaging Technology Drive Adoption of Precision-Guided Vertebroplasty
    • Shift Towards Minimally Invasive Techniques Over Traditional Open Surgeries Fuels Market Growth
    • Increasing Focus on Outpatient Settings Expands Market Reach for Vertebroplasty Services
    • Innovations in Bioactive Bone Cements Generate New Product Demand
    • Growing Popularity of Personalized, Patient-Specific Solutions Propels Market Expansion
    • Heightened Need for Effective Pain Management in Oncology Patients Increases Vertebroplasty Utilization
    • Wider Physician Training Programs Enhance Market Penetration of Vertebroplasty Procedures
    • Patient Preference for Shorter Recovery Time and Minimally Invasive Options Drives Adoption
    • Surging Healthcare Investments in Emerging Markets Open New Growth Opportunities
    • High Costs and Risk of Procedure-Related Complications Present Market Challenges
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Vertebroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Vertebroplasty Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • JAPAN
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CHINA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • EUROPE
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Vertebroplasty by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • GERMANY
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED KINGDOM
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SPAIN
    • TABLE 24: Spain Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Spain Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • RUSSIA
    • TABLE 26: Russia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Russia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF EUROPE
    • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Rest of Europe Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ASIA-PACIFIC
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 31: Asia-Pacific Historic Review for Vertebroplasty by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 32: Asia-Pacific 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 33: Australia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 34: Australia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • INDIA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 35: India Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: India Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SOUTH KOREA
    • TABLE 37: South Korea Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 38: South Korea Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF ASIA-PACIFIC
    • TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 40: Rest of Asia-Pacific Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • LATIN AMERICA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 41: Latin America Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: Latin America Historic Review for Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Latin America 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 44: Argentina Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Argentina Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • BRAZIL
    • TABLE 46: Brazil Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Brazil Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MEXICO
    • TABLE 48: Mexico Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Mexico Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF LATIN AMERICA
    • TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Latin America Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MIDDLE EAST
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 52: Middle East Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 53: Middle East Historic Review for Vertebroplasty by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 54: Middle East 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 55: Iran Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 56: Iran Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ISRAEL
    • TABLE 57: Israel Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 58: Israel Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SAUDI ARABIA
    • TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Saudi Arabia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED ARAB EMIRATES
    • TABLE 61: UAE Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 62: UAE Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF MIDDLE EAST
    • TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 64: Rest of Middle East Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • AFRICA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 65: Africa Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Africa Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

IV. COMPETITION